Search results (39)
« Back to NewsDecades old puzzle solved as scientists uncover cause of inflammatory bowel disease
22 June 2026
Researchers have identified a damaging immune response that helps explain a long-known genetic risk factor for inflammatory bowel disease, opening new possibilities for diagnosis and targeted treatment.
Professor David Church leads first trial of vaccine to prevent Lynch syndrome-associated cancers
12 June 2026
A new Oxford-led clinical trial will test an investigational mRNA vaccine designed to help prevent cancer in people with Lynch syndrome, an inherited condition associated with a high lifetime risk of several cancers.
Katherine Bull joins £5 million multi-modal imaging programme to improve understanding of disease
28 May 2026
Associate Professor Katherine Bull, Principal Investigator at the Centre for Human Genetics, is part of a new Wellcome-funded programme using advanced 3D imaging, spatial gene expression analysis and artificial intelligence to better understand disease.
New findings involving Nicky Whiffin’s team on RNU4-2-associated disorders published in Nature and Nature Genetics
10 April 2026
A major technological advance has revealed how mutations in a tiny non-coding gene can lead to multiple neurodevelopmental disorders, opening new avenues for diagnosis and research.
New research reveals optimal time intervals for COVID-19 vaccine boosters
18 September 2025
Two new papers from University of Oxford scientists have shown how the immune system reacts differently depending on the length of interval between vaccine doses.
Respiratory syncytial virus vaccine linked to reduced dementia risk
25 June 2025
A new study, co-led by researchers at the Centre for Human Genetics, shows that a vaccine against respiratory syncytial virus (RSV) is associated with a 29% reduction in dementia risk in the following 18 months. The findings suggest a novel explanation for how vaccines produce this effect.
Single cell biology of coeliac disease
7 May 2025
Research at the Centre for Human Genetics contributes to a study that identifies key immune structures in the gut that may drive coeliac disease.
Common virus may improve skin cancer treatment outcomes
1 May 2025
May is Skin Cancer Awareness Month, and a new study with input from researchers in the CHG has revealed that a common virus may positively influence how skin cancer patients respond to current treatments.
David Church awarded a Cancer Research UK Senior Cancer Research Fellowship
25 March 2025
David Church received a Senior Cancer Research Fellowship from the Cancer Research UK Research Careers Committee to study MHC-I and MHC-II dysregulation in colorectal & endometrial cancer.
Study finds previously unidentified genetic determinants of rare disease
28 February 2025
A landmark study involving researchers from the Centre for Human Genetics has identified 69 previously unidentified genetic determinants of rare disease, including uncommon forms of epilepsy and schizophrenia.